SNT 9465 seemed like a natural transition /progression from SNT 6302 , new formulation discovered whilst working on 6302, greater absorption effect and for a wider variety and age of scar tissue,,,
Prof Woods certainly likes the new formulation and with her extensive network can obviously see a clear path to commercialisation ,, more than likely utilising the same partners that she utilised for Spray on Skin?
9465 is an in- home application where as it looked like 6302 was application by a clinician.
Larger market for 9465 and Gary mentioned "looking to partner with cosmetic surgeons" big dollar market there alone but 9465 as the new SOC for fresh surgical scars would seem the world beater as there is no incumbent.
Appreciate your view that Management really haven't changed their spots.
I enjoy posting here while Fixed Margin Trades go through the machine , doing DD on new opportunities and watching the Portfolio , i'm across 14 Bio's currently ,, SNT is obviously the most near tern reward on the calendar,,, most of the day I'm entertained in the garage but when its been fine with no rain for a week I'll be down one of the gin clear rivers fishing for trout..
As you can tell I'm strong on SNT ,, multiple Phase II Assets and only an MC of $100m?
Plus SNT 5505 will fall into the deal zone in only a few weeks,,,
I'd like more updates on the UK Parkinson Trial ,,, NZT
Add to My Watchlist
What is My Watchlist?
